MUMBAI, INDIA—SEPTEMBER 28, 2012— DIA, the premier organization dedicated to knowledge exchange that fosters innovation to raise the level of health and well-being worldwide will host DIA India’s 7th Annual Conference Discovery through Commercialization: Innovative Strategies for Individualized Healthcare at the Hyderabad International Convention Center Novotel & HICC Complex in Hyderabad, India on November 1-4.
As the healthcare industry evolves, new methods and standards are being developed. This conference will focus on the discovery, development, manufacturing and commercialization to generate ground-breaking approaches to personalized health care. DIA India is also proud to present the Keynote Speaker, Paul Huckle, Senior Vice President, Global Regulatory Affairs, of GlaxoSmithKline.
Attendees can hear presenters at sessions within several conference tracks such as:
• Discovery
• Development
• Manufacturing
• Lean strategy
• Commercialization
• Technology and Standards
• Regulatory & Ethical issues
• Social and Legal Issues
• Plus tutorials on Bioinformatics and Personalized Medicine.
Chair advisory Council of India Larisa Nagra Singh, VP Global Functional Resourcing, Asia Quintiles, Singapore, says, “This meeting will bring to light the issues that the region has needed to address. The industry in India wishes to embrace forward-thinking processes, introducing conferences-goers to new technologies and standards and equipping them with functional tools to implement advanced strategies.”
Register for DIA India’s 7th Annual Conference Discovery through Commercialization: Innovative Strategies for Individualized Healthcare, contact Manoj.Trivedi@DIAIndia.org or here.
Register 10 people from your company and receive the 11th FREE!
Contact Rhean D’Souza for details on Rhean.Dsouza@diaindia.org or call +91.98.2058.7798, plus learn more about 2013 DIA India flagship conferences.
Follow #DIAIndiaAM2012 on Twitter for real time updates and news!
About DIA
DIA is a neutral, global, professional, member-driven association of nearly 18,000 professionals involved in the discovery, development, and life cycle management of pharmaceuticals, biotechnology, medical devices and related medical products. Through our international educational offerings and myriad networking opportunities, DIA provides a global forum for knowledge exchange that fosters the innovation of products, technologies and services to improve health and well being worldwide. Headquarters are in Horsham, PA, USA, with offices in Basel, Switzerland; Tokyo, Japan; Mumbai, India; and Beijing, China. Follow DIA on Facebook, Twitter, LinkedIn, and YouTube. Stay updated on hot topic news at #druginfoassn on Twitter. www.diahome.org.
